|
Innogenetics NV - Company Profile Snapshot
| Company Profile: |
Innogenetics NV |
| Ticker: |
INNX |
| Exchanges: |
FRA OTH |
| 2007 Sales: |
54,126,000 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Medical Services |
| Country: |
BELGIUM |
| Employees: |
466 |
Business Description
Innogenetics NV. The Group's principal activities are to provide diagnostic and therapeutic products using biotechnological research. The Diagnostics business focuses on infectious diseases, genetic testing, and neurodegeneration of many common diseases like HIV, Syphilis, Mycobacteria, Alzheimer's disease, HLA Class I and II etc. The Therapeutics division develops vaccines for infectious diseases for which current treatment options are limited. Their products include vaccines for Hepatitis B, Hepatitis C, Pulmonary Edema and other hard-to-heal wounds. The Group has operations in the United States, Germany, Spain, Italy, France, Brazil and the United Kingdom.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
